Centrexion Therapeutics

-$0.10 (-4.95%) As of 5:20 PM UTC today

Why Robinhood?

You can watch CNTX and buy or sell other stocks, options, and ETFs commission-free!

About CNTX

Context Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which is dedicated to improving the lives of women living with cancer. It engages in developing advanced small molecule and immunotherapy treatments to transform care for hormone-driven breast and gynecological cancers.

CEO
Martin A. Lehr
Employees
7
Headquarters
Philadelphia, Pennsylvania
Founded
2015

CNTX Key Statistics

Market cap
30.65M
Price-Earnings ratio
—
Dividend yield
—
Average volume
260.21K
High today
—
Low today
—
Open price
—
Volume
0.00
52 Week high
$10.87
52 Week low
$1.27
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure